Prostate MRI, with or without MRI‐targeted biopsy, and systematic biopsy for detecting prostate cancer
FJH Drost, DF Osses, D Nieboer… - Cochrane Database …, 2019 - cochranelibrary.com
Background Multiparametric magnetic resonance imaging (MRI), with or without MRI‐
targeted biopsy, is an alternative test to systematic transrectal ultrasonography‐guided …
targeted biopsy, is an alternative test to systematic transrectal ultrasonography‐guided …
Prostate magnetic resonance imaging, with or without magnetic resonance imaging-targeted biopsy, and systematic biopsy for detecting prostate cancer: a Cochrane …
FJH Drost, D Osses, D Nieboer, CH Bangma… - European urology, 2020 - Elsevier
Context Magnetic resonance imaging (MRI), with or without MRI-targeted biopsy (MRI
pathway), is an alternative test to systematic transrectal ultrasonography-guided biopsy in …
pathway), is an alternative test to systematic transrectal ultrasonography-guided biopsy in …
Extracellular vesicles in liquid biopsies: potential for disease diagnosis
J Liu, Y Chen, F Pei, C Zeng, Y Yao… - BioMed Research …, 2021 - Wiley Online Library
Liquid biopsy is conducted through minimally invasive or noninvasive procedures, and the
resulting material can be subjected to genomic, proteomic, and lipidomic analyses for early …
resulting material can be subjected to genomic, proteomic, and lipidomic analyses for early …
Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology
Liquid biopsy can quantify and qualify cell-free (cfDNA) and tumour-derived (ctDNA) DNA
fragments in the bloodstream. CfDNA quantification and mutation analysis can be applied to …
fragments in the bloodstream. CfDNA quantification and mutation analysis can be applied to …
Any correlation between prostate volume and incidence of prostate cancer: a review of reported data for the last thirty years
JR Yamashiro, WTW de Riese - Research and Reports in Urology, 2021 - Taylor & Francis
Purpose Prostate cancer (PCa) is the most common non-skin cancer in men worldwide and
more than 80% of men with PCa also have histo-anatomical findings of benign prostate …
more than 80% of men with PCa also have histo-anatomical findings of benign prostate …
Is greater patient involvement associated with higher satisfaction? Experimental evidence from a vignette survey
S Birkeland, M Bismark, MJ Barry… - BMJ quality & …, 2022 - qualitysafety.bmj.com
Background Patient-centredness is an essential quality parameter of modern healthcare.
Accordingly, involving patients in decisions about care is required by international laws and …
Accordingly, involving patients in decisions about care is required by international laws and …
Prostate-specific antigen (PSA) as a possible biomarker in non-prostatic cancer: A review
DC Pérez-Ibave, CH Burciaga-Flores… - Cancer …, 2018 - Elsevier
Prostate-specific antigen (PSA) is a serine protease produced by epithelial prostatic cells
and its main function is to liquefy seminal coagulum. Currently, PSA is a biomarker for the …
and its main function is to liquefy seminal coagulum. Currently, PSA is a biomarker for the …
Biomarkers that differentiate benign prostatic hyperplasia from prostate cancer: A literature review
CJ McNally, MW Ruddock, T Moore… - Cancer management …, 2020 - Taylor & Francis
Prediction of prostate cancer in primary care is typically based upon serum total prostate-
specific antigen (tPSA) and digital rectal examination results. However, these tests lack …
specific antigen (tPSA) and digital rectal examination results. However, these tests lack …
Amplification-free detection of circulating microRNA biomarkers from body fluids based on fluorogenic oligonucleotide-templated reaction between engineered …
GAD Metcalf, A Shibakawa, H Patel… - Analytical …, 2016 - ACS Publications
Highly abundant in cells, microRNAs (or miRs) play a key role as regulators of gene
expression. A proportion of them are also detectable in biofluids making them ideal …
expression. A proportion of them are also detectable in biofluids making them ideal …
Urinary RNA-based biomarkers for prostate cancer detection
F Martignano, L Rossi, A Maugeri, V Gallà… - Clinica Chimica …, 2017 - Elsevier
Prostate cancer (PCa) is the commonest malignancy in the male population worldwide.
Serum prostate specific antigen (PSA) test is the most important biomarker for the detection …
Serum prostate specific antigen (PSA) test is the most important biomarker for the detection …